OncoImmunology
Volume 9, 2020 - Issue 1
Open access
9,043
Views
54
CrossRef citations to date
0
Altmetric
Original Research
Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysis
Baihui Lia Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China;b National Clinical Research Center for Cancer, Tianjin, China;c Key Laboratory of Cancer Prevention and Therapy, Tianjin, China;d Tianjin’s Clinical Research Center for Cancer, Tianjin, China;e Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, ChinaView further author information
, Bailu Zhanga Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China;b National Clinical Research Center for Cancer, Tianjin, China;c Key Laboratory of Cancer Prevention and Therapy, Tianjin, China;d Tianjin’s Clinical Research Center for Cancer, Tianjin, China;e Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, ChinaView further author information
, Xuezhou Wanga Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China;b National Clinical Research Center for Cancer, Tianjin, China;c Key Laboratory of Cancer Prevention and Therapy, Tianjin, China;d Tianjin’s Clinical Research Center for Cancer, Tianjin, China;e Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, ChinaView further author information
, Ziqing Zenga Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China;b National Clinical Research Center for Cancer, Tianjin, China;c Key Laboratory of Cancer Prevention and Therapy, Tianjin, China;d Tianjin’s Clinical Research Center for Cancer, Tianjin, China;e Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, ChinaView further author information
, Ziqi Huanga Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China;b National Clinical Research Center for Cancer, Tianjin, China;c Key Laboratory of Cancer Prevention and Therapy, Tianjin, China;d Tianjin’s Clinical Research Center for Cancer, Tianjin, China;e Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, ChinaView further author information
, Lin Zhanga Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China;b National Clinical Research Center for Cancer, Tianjin, China;c Key Laboratory of Cancer Prevention and Therapy, Tianjin, China;d Tianjin’s Clinical Research Center for Cancer, Tianjin, China;e Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, ChinaView further author information
, Feng Weia Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China;b National Clinical Research Center for Cancer, Tianjin, China;c Key Laboratory of Cancer Prevention and Therapy, Tianjin, China;d Tianjin’s Clinical Research Center for Cancer, Tianjin, China;e Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, ChinaView further author information
, Xiubao Rena Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China;b National Clinical Research Center for Cancer, Tianjin, China;c Key Laboratory of Cancer Prevention and Therapy, Tianjin, China;d Tianjin’s Clinical Research Center for Cancer, Tianjin, China;e Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China;f Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, ChinaView further author information
& Lili Yanga Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China;b National Clinical Research Center for Cancer, Tianjin, China;c Key Laboratory of Cancer Prevention and Therapy, Tianjin, China;d Tianjin’s Clinical Research Center for Cancer, Tianjin, China;e Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, ChinaCorrespondence[email protected]
View further author information
show allView further author information
Article: 1807291
|
Received 16 Feb 2020, Accepted 31 Jul 2020, Published online: 28 Aug 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.